Comparative Evaluation of Initial and New Versions of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for Direct Detection of Mycobacterium tuberculosis in Respiratory and Nonrespiratory Specimens
- 1 March 1998
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 36 (3) , 684-689
- https://doi.org/10.1128/jcm.36.3.684-689.1998
Abstract
We evaluated the initial version of the Amplified Mycobacterium Tuberculosis Direct Test (Gen-Probe) (AMTDT 1) and the new version of AMTDT (AMTDT 2) for the detection of Mycobacterium tuberculosis directly from respiratory and nonrespiratory samples and compared the results with those of culture and staining methods. The assays were applied to 410 respiratory and 272 nonrespiratory samples collected from 515 patients. The combination of the culture results and clinical diagnosis was considered to be the “gold standard.” Ninety-five respiratory specimens were collected from 67 patients with a diagnosis of pulmonary tuberculosis (TB) and 68 nonrespiratory specimens were collected from 61 patients with a diagnosis of extrapulmonary TB. With respiratory specimens, the sensitivity, specificity, and positive and negative predictive values were 83, 100, 100, and 96%, respectively, for AMTDT 1 and 94.7, 100, 100, and 98.4%, respectively, for AMTDT 2. With nonrespiratory specimens, the sensitivity, specificity, and positive and negative predictive values were 83, 100, 100, and 94%, respectively, for AMTDT 1 and 86.8, 100, 100, and 98.4%, respectively, for AMTDT 2. The overall results of AMTDT 1 and AMTDT 2 were concordant for 97% (661 of 682) of the samples. Statistically significant differences in sensitivities were found between AMTDT 1 and AMTDT 2 with respiratory specimens. It was concluded that although both nucleic acid amplification methods are rapid, sensitive, and specific for the detection of M. tuberculosis complex in all types of clinical samples, AMTDT 2 appeared to be more sensitive than AMTDT 1 when applied to smear-negative specimens. In contrast AMTDT 2 is more susceptible than AMTDT 1 to inhibitory substances in the amplification reaction. The turnaround time of AMTDT 2 is shorter (3.5 h) than that for AMTDT 1 (5 h).Keywords
This publication has 29 references indexed in Scilit:
- Current Laboratory Methods for the Diagnosis of TuberculosisPublished by American Society for Microbiology ,2014
- Cultivation of Mycobacterium tuberculosis for Research PurposesPublished by American Society for Microbiology ,2014
- Evaluation of a commercial rRNA amplification assay for direct detection ofMycobacterium tuberculosis in processed sputumEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Screening of respiratory tract specimens for the presence of Mycobacterium tuberculosis by using the Gen-Probe Amplified Mycobacterium Tuberculosis Direct TestJournal of Clinical Microbiology, 1994
- Simple method for production of internal control DNA for Mycobacterium tuberculosis polymerase chain reaction assaysJournal of Clinical Microbiology, 1993
- Diagnosis of tuberculosis by DNA amplification in clinical practice evaluationThe Lancet, 1991
- The rapid diagnosis of tuberculosis: a selective review.1990
- RAPID DIAGNOSIS OF TUBERCULOSIS BY AMPLIFICATION OF MYCOBACTERIAL DNA IN CLINICAL SAMPLESPublished by Elsevier ,1989
- Comparison of two pretreatment methods for the detection of mycobacteria of BACTEC and Lowenstein-Jensen slantsJournal of Microbiological Methods, 1987
- [Media and methods of culture suitable for the reanimation and multiplication in vitro of Mycobacterium tuberculosis of reduced vitality, of ephemeral viability, or in a state of quiescence].1960